Lynx1 Capital Management LP - 31 Dec 2024 SCHEDULE 13G/A Report for TScan Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (TCRX)

Filing Manager: Lynx1 Capital Management LP
Reporting Manager: Lynx1 Capital Management LP
Security: TScan Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share
Symbol: TCRX
Shares outstanding: 49,149,972 shares
Disclosed Ownership: 5,357,347 shares
Ownership: 10.9%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 09:00:17 UTC
Date of event: 31 Dec 2024
Next filing: 14 Aug 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Lynx1 Capital Management LP	10.9%	5,357,347	0	5,357,347	/s/ Weston Nichols	By: Lynx1 Capital Management GP LLC, General Partner, By: Weston Nichols, Sole Member
Weston Nichols	10.9%	5,357,347	0	5,357,347	/s/ Weston Nichols	Weston Nichols, Individually